TY  - CHAP
AU  - Julian P. Legg
ED  - Bernhard Resch
Y1  - 2019-10-30
PY  - 2019
T1  - Disease Severity in Respiratory Syncytial Virus Infection: Role of Viral and Host Factors
N2  - Respiratory syncytial virus (RSV) causes seasonal epidemics during the winter and wet seasons, particularly in young children. Although there is one drug available for prophylaxis, palivizumab, it is indicated for high-risk children only. Therefore a vaccine is urgently needed. This book provides an overview of RSV and discusses its incidence and presentation in different populations, including preterm infants and children with congenital heart disease. It also discusses future strategies for RSV prophylaxis and developments in and barriers to creating a viable vaccine.
BT  - The Burden of Respiratory Syncytial Virus Infection in the Young
SP  - Ch. 1
UR  - https://doi.org/10.5772/intechopen.88782
DO  - 10.5772/intechopen.88782
SN  - 978-1-78984-643-0
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-25
ER  -